Aesthetics Journal: Allergan And Intas Pharmaceuticals In Agreement After Trademark Debate

US pharmaceutical company Allergan has entered into a settlement with Indian manufacturer Intas Pharmaceuticals on the use of the trademarks ‘Botox’ and ‘BTX-A’ for botulinum toxin. The court order, which was issued on September 9 in the Delhi High Court, stated, “The defendant (Intas Pharmaceuticals) has acknowledged the plaintiff’s (Allergan) exclusive rights in respect of … Continue reading Aesthetics Journal: Allergan And Intas Pharmaceuticals In Agreement After Trademark Debate